Aggregated News
One could argue that stem cell research is currently the most promising area of biomedical research. It is no surprise that this year's Nobel Prize in Medicine went to a duo that work in the area. But much of the press coverage associated with the field falls squarely in the too-good-to-be true category. It is this sort of unsubstantiated hype that contributes to inappropriate public expectations and the legitimization of bogus therapies.
A new and troubling dimension to the hype has emerged: the well-publicized use of "stem cell therapies" by high-profile athletes.
The phenomenon has been around for a few years. The first big stem-cells-help-athlete story seems to have been the 2011 story of New York Yankee pitcher, Bartolo Colon. He received cell therapy for a chronic shoulder injury. Then, also in 2011, came the story about Peyton Manning's neck treatments in Germany. There here have since been dozens of similar articles. Google "NFL and stem cell therapy" and what you get is a bunch of stories about football players receiving allegedly cutting-edge cell treatments from practitioners throughout...
A new and troubling dimension to the hype has emerged: the well-publicized use of "stem cell therapies" by high-profile athletes.
The phenomenon has been around for a few years. The first big stem-cells-help-athlete story seems to have been the 2011 story of New York Yankee pitcher, Bartolo Colon. He received cell therapy for a chronic shoulder injury. Then, also in 2011, came the story about Peyton Manning's neck treatments in Germany. There here have since been dozens of similar articles. Google "NFL and stem cell therapy" and what you get is a bunch of stories about football players receiving allegedly cutting-edge cell treatments from practitioners throughout...